ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

16 Tips from 16 Years Sick

Fibromyalgia Fare Fit for All Seasons

New Study Shows Artificial Sweeteners Lead to Diabetes

Essential Oils — An Effective and Healthy Option to Treat Headaches

Higher vitamin D levels associated with less severe disease in NAFLD patients

Krill Oil: Make This Omega-3 Supplement Part of Your Health Regimen

How zinc helps fight esophageal cancer

Everything You Need to Know About Black Cohosh

Low vitamin D levels predict ED in diabetics

Let Sweet Basil Oil Boost Your Health Today

 
Print Page
Email Article

Neurochem to begin phase 3 clinical trials for Alzheimer's drug in June

  [ 55 votes ]   [ Discuss This Article ]
www.ProHealth.com • May 19, 2004


Canadian Press May 19, 2004 MONTREAL (CP) - Neurochem Inc. plans to start final clinical trials next month in North America for its anti-Alzheimer's disease drug Alzhemed, the chief executive told the company's annual meeting Wednesday. Francesco Bellini said the phase three trials, lasting 18 months, will require about 950 Alzheimer's patients with a mild to moderate form of the disease, which gradually reduces memory.

Bellini described the drug as a potential block-buster that could bring huge profits to Neurochem and its shareholders. "This has a potential to be a multibillion-dollar drug," Bellini told the meeting. But he warned the clinical trials will cost $30 million US in both North America and Europe. He said there is currently no medication to treat Alzheimer's, which currently affects more than 4.5 million people in the United States alone, a figure expected to triple as the population ages.

More than 70 clinical sites have been identified to administer the drug, including 19 in Canada. Neurochem is negotiating with potential commercial partners for Alzhemed, but Bellini said he is in no hurry to strike a deal. The company, formed in 2000, has not yet had any revenues let alone profits as it attempts to bring to market three drugs in its pipeline. Bellini said none of them has a competitor.

Bellini said Neurochem expects to reap its first revenues by the end of 2005 from Febrillex for the treatment of amyloidosis, a consequence of chronic inflammatory and infectious diseases such as rheumatoid arthritis. He said the market in industrialized countries for Febrillex is estimated at between $500 million US and $1 billion. Neurochem (TSX:NRM) stock was off 90 cents at $31.35 in midday trading. © The Canadian Press 2004



Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Vitamin D3 Extreme™ Mitochondria Ignite™ with NT Factor®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Vitamin K-2 – A Key Player in Cardiovascular and Bone Health Vitamin K-2 – A Key Player in Cardiovascular and Bone Health
The Super Antioxidant for Brain, Joint and Heart Health The Super Antioxidant for Brain, Joint and Heart Health
Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging
The Curcumin Revolution: 'Golden' Ticket to Better Health The Curcumin Revolution: 'Golden' Ticket to Better Health
How to Jump-start and Sustain Energy Production in CFS How to Jump-start and Sustain Energy Production in CFS

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map